drugset / Trial / NCT02901067
STAT-STatin and Aspirin in Trauma
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase II, pragmatic, prospective, randomized, double-blind, adaptive clinical trial examining the efficacy of statins and aspirin in the reduction of acute lung injury and venous thromboembolism in patients with fibrinolysis shutdown.
Timeline
- Start
- 2017-02-03
- Primary completion
- 2021-05-24
- Completion
- 2021-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 325 mg | Oral |
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |